Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy

Androgen up-regulates vascular endothelial growth factor expression in prostate cancer cells via an Sp1 binding site

(2013) Kurtis Eisermann et al.   Molecular Cancer

CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34

(2013) Yasuyoshi Miyata et al.   VIRCHOWS ARCHIV

Tumor-associated Stromal Cells Expressing E-prostanoid 2 or 3 Receptors in Prostate Cancer: Correlation With Tumor Aggressiveness and Outcome by Angiogenesis and Lymphangiogenesis

(2012) Yasuyoshi Miyata et al.   UROLOGY

Castration resistant prostate cancer is associated with increased blood vessel stabilization and elevated levels of VEGF and Ang-2

(2011) Tajana Tešan Tomić et al.   PROSTATE

Thrombospondin-1 regulates the normal prostate in vivo through angiogenesis and TGF-β activation

(2010) Philip P Fitchev et al.   LABORATORY INVESTIGATION

Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study

(2009) Jennifer M. Rubatt et al.   GYNECOLOGIC ONCOLOGY

Prognostic value of microvessel density in prostate cancer: a tissue microarray study

(2009) Andreas Erbersdobler et al.   WORLD JOURNAL OF UROLOGY